Article 101

Pharma and Biotech In-licensing and Collaboration Agreements: a Deal Lawyer’s Guide to EU Anti-trust pitfalls

By Inside EU Life Sciences on January 4, 2007

Posted in Corporate

Article originally published in the Cross-border Life Sciences Handbook 2006/07

Pharmaceutical and biotech companies are turning with increasing frequency to in-licensing and collaboration agreements – pharmaceutical companies to put new products in their pipelines and biotech companies to access the resources needed for final-stage development, clinical trials, manufacturing, and distribution.
Continue Reading Pharma and Biotech In-licensing and Collaboration Agreements: a Deal Lawyer’s Guide to EU Anti-trust pitfalls

Parallel Trade in Pharmaceutical Products in Europe: The European Court of Justice’s Ruling in Syfait v. GSK

By Peter Bogaert on June 1, 2005

Posted in Competition

Originally published as Covington Life Sciences Alert on June 1st, 2005

May a dominant pharmaceutical company refuse to supply in full the orders it receives from a wholesaler in an EU country in order to limit parallel trade in its products in the European Union? This was the question put…
Continue Reading Parallel Trade in Pharmaceutical Products in Europe: The European Court of Justice’s Ruling in Syfait v. GSK